DOI:

10.37988/1811-153X_2022_2_94

Potential COVID-19 complications in oral cavity and maxillofacial area

Authors

  • I.N. Antonova 1, PhD in Medical Sciences, full professor of the Dentistry diseases propaedeutics Department, director of the Dentistry and maxillofacial surgery research Institute
    ORCID: 0000-0003-2543-6137
  • A.P. Grygoriants 1, PhD in Medical Sciences, associate professor of the Dentistry diseases propaedeutics Department
    ORCID: 0000-0001-7518-4279
  • N.V. Kalakutskiy 1, PhD in Medical Sciences, full professor of the Dental and maxillofacial surgery Department
    ORCID: 0000-0002-6851-5073
  • O.Yu. Petropavlovskaya 1, PhD in Medical Sciences, associate professor of the Dental and maxillofacial surgery Department
    ORCID: 0000-0002-2164-6092
  • A.A. Grygoriants 1, PhD in Medical Sciences, assistant professor of the Dentistry diseases propaedeutics Department
    ORCID: 0000-0003-4681-212X
  • A.S. Samodurov 1, senior laboratory technician at the Dentistry diseases propaedeutics Department
    ORCID: 0000-0002-3111-353X
  • 1 Pavlov University, 197022, Saint-Petersburg, Russia

Abstract

At the moment, COVID-19 is one of the most urgent pathologies, affecting the practice of doctors of various specialties. Despite this, very little is known about all the pathogenetic mechanisms of the development of a local and systemic response, and, accordingly, about all forms of manifestation of COVID-19. This article discusses the clinical manifestation of COVID-19 complications in oral cavity and maxillofacial localisation based on data from recent publications. Oral manifestations included variable mucosal lesions consistent with diagnoses such as aphthous stomatitis, herpetiform lesions, candidiasis, vasculitis, mucositis, necrotizing periodontal disease, angular cheilitis, Melkerson-Rosenthal syndrome. One of the important trends is the growth of concomitant fungal infections caused by Mucor, Rhizomucor and Aspergillus. Most often, especially in foreign sources, there was a description of rhino-orbito-cerebral acute invasive fungal rhinosinusitis, which is a potentially life-threatening fungal infection. The development of such a complication of COVID-19 can be associated with several factors, such as the nature of the immune response when the organism is damaged by the SARS-CoV-2 and the active prescription of antibiotic therapy. In the presence of an initial lesion in the sinonasal localization, the orbit is quickly involved in the pathological process, and then invasion of the cavernous sinus becomes possible. Intracranial complications include leptomeningitis or cerebritis and intracranial abscess. The nature of the changes is similar to the manifestations in sinusitis developing in connection with red bone marrow transplantation, respectively, we can assume a similar level of immunosuppression in the defeat of COVID-19. Another important distinguishing feature of the complications of coronavirus infection is the occurrence of a generalized prothrombotic state with subsequent microvascular and macrovascular thromboembolism. The most common reports are pulmonary embolism, deep vein thrombosis, cerebral infarction, and cerebral venous sinus thrombosis. In the maxillofacial localization, manifestations are possible in the form of necrotic changes in the facial bones associated with arterial thrombosis. Thus, based on the analyzed scientific publications, COVID-19 is a multisystem disease with the development of characteristic complications in the oral cavity and maxillofacial localization.

Key words:

COVID-19, sinusitis, thrombosis

For Citation

[1]
Antonova I.N., Grygoriants A.P., Kalakutskiy N.V., Petropavlovskaya O.Yu., Grygoriants A.A., Samodurov A.S. Potential COVID-19 complications in oral cavity and maxillofacial area. Clinical Dentistry (Russia).  2022; 25 (2): 94—99. DOI: 10.37988/1811-153X_2022_2_94

References

  1. Morens D.M., Daszak P., Markel H., Taubenberger J.K. Pandemic COVID-19 joins history‘s pandemic legion. — mBio. — 2020, 11 (3): e00812—20. PMID: 32471830
  2. Liu Y.C., Kuo R.L., Shih S.R. COVID-19: The first documented coronavirus pandemic in history. — Biomed J. — 2020, 43 (4): 328—333. PMID: 32387617
  3. Salian V.S., Wright J.A., Vedell P.T., Nair S., Li C., Kandimalla M., Tang X., Carmona Porquera E.M., Kalari K.R., Kandimalla K.K. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm. — 2021, 18 (3): 754—771. PMID: 33464914
  4. Gu J., Han B., Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. — Gastroenterology. — 2020, 158 (6): 1518—1519. PMID: 32142785
  5. El-Anwar M.W., Elzayat S., Fouad Y.A. ENT manifestation in COVID-19 patients. — Auris Nasus Larynx. — 2020, 47 (4): 559—564. PMID: 32586739
  6. Özçelik Korkmaz M., Eğilmez O.K., Özçelik M.A., Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. — Eur Arch Otorhinolaryngol. — 2021, 278 (5): 1675—1685. PMID: 33011957
  7. Makedonova Yu.A., Poroisky S.V., Gavrikova L.M., Afanaseva O.Y. Manif estat ion of the oral mucosa diseases in patients with COVID-19. — Vestnik VSMU. — 2021, 1 (77): 110—115 (In Russ.). eLIBRARY ID: 45153499
  8. Kolchanova N., Manak T., Okulich V. The state of the biological system of the oral cavity in patients after COVID-19. — Sovremennaya stomatologiya. 2021, 1 (82): 54—58 (In Russ.). eLIBRARY ID: 44930163
  9. Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and ageusia: Common findings in COVID-19 patients. — Laryngoscope. — 2020, 130 (7): 1787. PMID: 32237238
  10. Amorim Dos Santos J., Normando A.G.C., Carvalho da Silva R.L., De Paula R.M., Cembranel A.C., Santos-Silva A.R., Guerra E.N.S. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? — Int J Infect Dis. — 2020, 97: 326—328. PMID: 32526392
  11. Iranmanesh B., Khalili M., Amiri R., Zartab H., Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. — Dermatol Ther. — 2021, 34 (1): e14578. PMID: 33236823
  12. Sinadinos A., Shelswell J. Oral ulceration and blistering in patients with COVID-19. — Evid Based Dent. — 2020, 21 (2): 49. PMID: 32591655
  13. Gavrikova L.M., Makedonova Y.U.A., Dyachenko S.V. Assessment of dental status of patients with COVID-19. — Medical and pharmaceutical journal Pulse. — 2021, 10: 50—55 (In Russ.). eLIBRARY ID: 47577774
  14. Al-Khatib A. Oral manifestations in COVID-19 patients. — Oral Dis. — 2021, 27 Suppl 3: 779—780. PMID: 32521067
  15. Wadia R. COVID-19 — oral manifestations. — Br Dent J. — 2020, 229 (10): 669. PMID: 33247257
  16. Corchuelo J., Ulloa F.C. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. — Int J Infect Dis. — 2020, 100: 154—157. PMID: 32882435
  17. Borisova E.G., Mashkova N.G., Pototskaya A.V. Manifestation of dental pathology after a possible coronaviral infection. — Medical and pharmaceutical journal Pulse. — 2021, 12: 13—20 (In Russ.). eLIBRARY ID: 47573943
  18. Patel J., Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID-19. — Oral Dis. — 2021, 27 Suppl 3: 768—769. PMID: 32506662
  19. Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M., Satta G., Cooke G., Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. — Clin Infect Dis. — 2020, 71 (9): 2459—2468. PMID: 32358954
  20. Ripa M., Galli L., Poli A., Oltolini C., Spagnuolo V., Mastrangelo A., Muccini C., Monti G., De Luca G., Landoni G., Dagna L., Clementi M., Rovere Querini P., Ciceri F., Tresoldi M., Lazzarin A., Zangrillo A., Scarpellini P., Castagna A., COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. — Clin Microbiol Infect. — 2021, 27 (3): 451—457. PMID: 33223114
  21. Belotserkovskaia Y.G., Romanovskikh A.G., Smirnov I.P. COVID-19: a respiratory infection caused by new coronavirus: new data on epidemiology, clinical course, and patients management. — Consilium Medicum. — 2020, 3: 12—20 (In Russ.). eLIBRARY ID: 42745698
  22. Duryagina L.Kh., Sataeva T.P., Degtyareva L.A., Postnikova O.N., Dubrovina-Parus T.A. Candidiasis lesions of the oral mucosa in patients with COVID-19: tactics of patient management, therapy correction. — Crimean Journal of Internal Diseases. — 2021, 3: 40—43 (In Russ.). eLIBRARY ID: 47190240
  23. Seaton R.A., Gibbons C.L., Cooper L., Malcolm W., McKinney R., Dundas S., Griffith D., Jeffreys D., et al. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. — J Infect. — 2020, 81 (6): 952—960. PMID: 32987097
  24. Bhattacharyya A., Sarma P., Kaur H., Kumar S., Bhattacharyya J., Prajapat M., Prakash A., Sharma S., Reddy D.H., Thota P., Bansal S., Gautam B.S., Medhi B. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. — Indian J Pharmacol. — 2021, 53 (6): 499—510. PMID: 34975140
  25. Ashour M.M., Abdelaziz T.T., Ashour D.M., Askoura A., Saleh M.I., Mahmoud M.S. Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature. — J Neuroradiol. — 2021, 48 (5): 319—324. PMID: 34087330
  26. Song G., Liang G., Liu W. Fungal co-infections associated with global COVID-19 pandemic: A clinical and diagnostic perspective from China. — Mycopathologia. — 2020, 185 (4): 599—606. PMID: 32737747
  27. Subramani M., Shankaran S. Bacterial sinusitis in the COVID-19 era: A reminder for antibiotic stewardship. — Cureus. — 2021, 13 (11): e19453. PMID: 34926027
  28. El-Kholy N.A., El-Fattah A.M.A., Khafagy Y.W. Invasive fungal sinusitis in post COVID-19 patients: A new clinical entity. — Laryngoscope. 2021, 131 (12): 2652—2658. PMID: 34009676
  29. Mehta S., Pandey A. Rhino-orbital mucormycosis associated with COVID-19. — Cureus. — 2020, 12 (9): e10726. PMID: 33145132
  30. Manchanda S., Semalti K., Bhalla A.S., Thakar A., Sikka K., Verma H. Revisiting rhino-orbito-cerebral acute invasive fungal sinusitis in the era of COVID-19: pictorial review. — Emerg Radiol. — 2021, 28 (6): 1063—1072. PMID: 34463864
  31. Thajeb P., Thajeb T., Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. — Scand J Infect Dis. — 2004, 36 (9): 643—8. PMID: 15370650
  32. Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated characteristics. — Otolaryngol Head Neck Surg. — 2020, 163 (1): 114—120. PMID: 32423357
  33. Brondfield S., Kaplan L., Dhaliwal G. Palatal mucormycosis. — J Gen Intern Med. — 2018, 33 (10): 1815. PMID: 30088205
  34. Pai V., Sansi R., Kharche R., Bandili S.C., Pai B. Rhino-orbito-cerebral mucormycosis: Pictorial review. — Insights Imaging. — 2021, 12: 167. PMID: 34786029
  35. Garg R., Bharangar S., Gupta S., Bhardwaj S. Post COVID-19 infection presenting as rhino-orbital mycosis. — Indian J Otolaryngol Head Neck Surg. — 2021, 1—8 (online ahead of print). PMID: 34307112
  36. Wang H., Song J., Pan L., Yao Y., Deng Y.K., Wang Z.C., Liao B., Ma J., He C., Zeng M., Liu Z. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19. — J Allergy Clin Immunol Pract. — 2020, 8 (10): 3597—3599.e2. PMID: 32980581
  37. Mohammadi F., Badri M., Safari S., Hemmat N. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update. — BMC Infect Dis. — 2021, 21 (1): 906. PMID: 34479495
  38. Talmi Y.P., Goldschmied-Reouven A., Bakon M., Barshack I., Wolf M., Horowitz Z., Berkowicz M., Keller N., Kronenberg J. Rhino-orbital and rhino-orbito-cerebral mucormycosis. — Otolaryngol Head Neck Surg. — 2002, 127 (1): 22—31. PMID: 12161726
  39. Makovskaya N.I., Vasilyev A.V. Features of the work of a dentist and maxillofacial surgeon in a pandemic of a new coronavirus infection (COVID-19). World experience and own practice. — Parodontologiya. — 2020, 3: 185—188 (In Russ.). eLIBRARY ID: 43865431
  40. Drozd-Sokolowska J.E., Sokolowski J., Wiktor-Jedrzejczak W., Niemczyk K. Sinusitis in patients undergoing allogeneic bone marrow transplantation — a review. — Braz J Otorhinolaryngol. — 2017, 83 (1): 105—111. PMID: 27184506
  41. Shires C.B., Klug T., Dryden S., Ford J. Unusual cause of acute sinusitis and orbital abscess in COVID-19 positive patient: Case report. — Int J Surg Case Rep. — 2021, 79: 164—168. PMID: 33477076
  42. de Roquetaillade C., Chousterman B.G. et al. Unusual arterial thrombotic events in COVID-19 patients. — Int J Cardiol. — 2021, 323: 281—284. PMID: 32918938
  43. Gómez-Mesa J.E., Galindo-Coral S., Montes M.C., Muñoz Martin A.J. Thrombosis and coagulopathy in COVID-19. — Curr Probl Cardiol. 2021, 46 (3): 100742. PMID: 33243440
  44. Long B., Bridwell R., Gottlieb M. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. — Am J Emerg Med. — 2021, 49: 58—61. PMID: 34062319
  45. Chan N.C., Weitz J.I. COVID-19 coagulopathy, thrombosis, and bleeding. — Blood. — 2020, 136 (4): 381—383. PMID: 32702124
  46. Mei H., Luo L., Hu Y. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. — J Hematol Oncol. — 2020, 13 (1): 161. PMID: 33261634
  47. Wool G.D., Miller J.L. The impact of COVID-19 disease on platelets and coagulation. — Pathobiology. — 2021, 88 (1): 15—27. PMID: 33049751
  48. Kashi M., Jacquin A., Dakhil B., Zaimi R., Mahé E., Tella E., Bagan P. Severe arterial thrombosis associated with COVID-19 infection. — Thromb Res. — 2020, 192: 75—77. PMID: 32425264
  49. Katneni U.K., Alexaki A., et al. Coagulopathy and thrombosis as a result of severe COVID-19 infection: A microvascular focus. Thromb Haemost. — 2020, 120 (12): 1668—1679. PMID: 32838472
  50. Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. — 2020, 41 (32): 3038—3044. PMID: 32882706
  51. Sedlaczek O., Wagner W., Dempfle C.E. [COVID-19-induced coagulopathy and thrombosis manifestations]. — Radiologe. — 2021, 61 (10): 909—914 (In German). PMID: 34559248
  52. Leisman D.E., Deutschman C.S., Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. — Intensive Care Med. — 2020, 46 (6): 1105—1108. PMID: 32347323
  53. Costanzo L., Failla G., Antignani P.L., Fareed J., Gu Y., Pitha J., Aluigi L., Karplus T., Mansilha A. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. — Int Angiol. 2020, 39 (6): 445—451. PMID: 32892615
  54. Karimzadeh S., Dong V., Hassan O.G., Raut A., Fouda A., Parrill A., Eaton K., Huy N.T. COVID-19-induced coagulopathy and observed benefits with anticoagulation. — Transfus Apher Sci. — 2020, 59 (6): 102906. PMID: 32778522
  55. Ahmed O., Aladham Y., Mahmood S., Abdelnaby M.M. Complicated sinusitis with sphenopalatine artery thrombosis in a COVID-19 patient: a case report. — J Surg Case Rep. — 2021, 2021 (3): rjab010. PMID: 33732419

Received

March 29, 2022

Published on

June 1, 2022